Host Directed Therapy for Chronic Tuberculosis via Intrapulmonary Delivery of Aerosolized Peptide Inhibitors Targeting the IL-10-STAT3 Pathway
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Host Directed Therapy for Chronic Tuberculosis via Intrapulmonary Delivery of Aerosolized Peptide Inhibitors Targeting the IL-10-STAT3 Pathway ; volume:8 ; number:1 ; day:9 ; month:11 ; year:2018 ; pages:1-14 ; date:12.2018
Scientific reports ; 8, Heft 1 (9.11.2018), 1-14, 12.2018
- Creator
-
Upadhyay, Rashmi
Sanchez-Hidalgo, Andrea
Wilusz, Carol J.
Lenaerts, Anne J.
Arab, Jennifer
Yeh, Joanna
Stefanisko, Karen
Tarasova, Nadya I.
Gonzalez-Juarrero, Mercedes
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-35023-0
- URN
-
urn:nbn:de:101:1-2018122321215342337726
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Upadhyay, Rashmi
- Sanchez-Hidalgo, Andrea
- Wilusz, Carol J.
- Lenaerts, Anne J.
- Arab, Jennifer
- Yeh, Joanna
- Stefanisko, Karen
- Tarasova, Nadya I.
- Gonzalez-Juarrero, Mercedes
- SpringerLink (Online service)
Other Objects (12)
Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review
Nanomaterial-mediated host directed therapy of tuberculosis by manipulating macrophage autophagy
Host-directed therapy against tuberculosis through targeting eicosanoid pathway key enzymes
Small lipid mediators in experimental tuberculosis as target for host-directed therapy
Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis
Rv2231c, a unique histidinol phosphate aminotransferase from Mycobacterium tuberculosis, supports virulence by inhibiting host-directed defense
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy
MAIT cell-directed therapy of Mycobacterium tuberculosis infection
Natriuretic peptide-directed medical therapy: a systematic review
Host-directed therapeutic approaches against hyperinflammatory respiratory viruses
Asymmetric synthesis of host-directed inhibitors of myxoviruses
Immune responses in the treatment of drug-sensitive pulmonary tuberculosis with phenylbutyrate and vitamin D3 as host directed therapy
Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review
Nanomaterial-mediated host directed therapy of tuberculosis by manipulating macrophage autophagy
Host-directed therapy against tuberculosis through targeting eicosanoid pathway key enzymes
Small lipid mediators in experimental tuberculosis as target for host-directed therapy
Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis
Rv2231c, a unique histidinol phosphate aminotransferase from Mycobacterium tuberculosis, supports virulence by inhibiting host-directed defense
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy
MAIT cell-directed therapy of Mycobacterium tuberculosis infection
Natriuretic peptide-directed medical therapy: a systematic review
Host-directed therapeutic approaches against hyperinflammatory respiratory viruses
Asymmetric synthesis of host-directed inhibitors of myxoviruses
Immune responses in the treatment of drug-sensitive pulmonary tuberculosis with phenylbutyrate and vitamin D3 as host directed therapy
Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review
Nanomaterial-mediated host directed therapy of tuberculosis by manipulating macrophage autophagy
Host-directed therapy against tuberculosis through targeting eicosanoid pathway key enzymes
Small lipid mediators in experimental tuberculosis as target for host-directed therapy
Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis
Rv2231c, a unique histidinol phosphate aminotransferase from Mycobacterium tuberculosis, supports virulence by inhibiting host-directed defense
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy
MAIT cell-directed therapy of Mycobacterium tuberculosis infection
Natriuretic peptide-directed medical therapy: a systematic review
Host-directed therapeutic approaches against hyperinflammatory respiratory viruses
Asymmetric synthesis of host-directed inhibitors of myxoviruses